Exposure to corticosteroids in pregnancy is associated with adverse perinatal outcomes among infants of mothers with inflammatory bowel disease: results from the PIANO registry
| Autor: | Florence-Damilola, Odufalu, Millie, Long, Kirk, Lin, Uma, Mahadevan, Vinita, Jacob |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
Neonatal intensive care unit Offspring Cleft Lip Intrauterine growth restriction Inflammatory bowel disease Adrenal Cortex Hormones Pregnancy medicine Humans Prospective Studies Crohn's disease business.industry Obstetrics Infant Newborn Pregnancy Outcome Gastroenterology Inflammatory Bowel Diseases medicine.disease Cleft Palate Pregnancy Complications Low birth weight Premature Birth Small for gestational age Female medicine.symptom business |
| Zdroj: | Gut. 71:1766-1772 |
| ISSN: | 1468-3288 0017-5749 |
| DOI: | 10.1136/gutjnl-2021-325317 |
| Popis: | ObjectiveActive inflammatory bowel disease (IBD) during pregnancy may require the use of corticosteroids. The aim of this study was to investigate the impact of in utero corticosteroid exposure on adverse pregnancy outcomes, congenital malformations, infections and neurocognitive development among offspring of mothers with IBD.DesignUsing the prospective Pregnancy in Inflammatory Bowel Disease and Neonatal Outcomes registry, data were collected at each trimester, delivery; and in the 12 months post partum. Bivariate statistics and multivariate logistic regression models compared pregnancy outcomes by corticosteroid exposure.ResultsA total of 1490 mothers with IBD were enrolled, with 1431 live births recorded. Corticosteroid use was associated with increased risk of preterm birth, small for gestational age, low birth weight (LBW), intrauterine growth restriction and neonatal intensive care unit (NICU) admission. On adjusted multivariate models, corticosteroid use was associated with preterm birth (OR 1.79, 95% CI 1.18 to 2.73), LBW (OR 1.76, 95% CI 1.07 to 2.88) and NICU admission (OR 1.54, 95% CI 1.03 to 2.30). Late corticosteroid use (second and/or third trimester) was associated with serious infections at 9 and 12 months (4% vs 2% and 5% vs 2%, respectively, p=0.03 and p=0.001). There were five newborns with in utero corticosteroid exposure born with orofacial clefts versus one without corticosteroid exposure. Developmental milestones were similar across corticosteroid exposure groups.ConclusionIn this prospective pregnancy registry, offspring of women exposed to corticosteroids during pregnancy were more likely to have adverse pregnancy outcomes. This emphasises the importance of controlling disease activity before and during pregnancy with steroid-sparing therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|